Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (HUF)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Pharmaceuticals - Women's Healthcare (WHC)

- - 26TCr 29TCr 33TCr

Gross Profit

- - 17TCr 19TCr 22TCr

Operating Income

- - 3.94TCr 4.43TCr 5.31TCr

Pharmaceuticals - Neuropsychiatry (CNS)

- - 21TCr 24TCr 26TCr

Gross Profit

- - 20TCr 24TCr 26TCr

Operating Income

- - 17TCr 21TCr 23TCr

Pharmaceuticals - General Medicines (GM)

- - 23TCr 25TCr 25TCr

Gross Profit

- - 12TCr 13TCr 13TCr

Operating Income

- - 4.33TCr 4TCr 3.7TCr

Pharmaceuticals - Pharma Other

- - 1.3TCr 1.11TCr 699.4Cr

Gross Profit

- - 173.1Cr 29Cr -171.2Cr

Operating Income

- - -62Cr -167.5Cr -317.5Cr

Pharmaceuticals

51TCr 66TCr - - -

Total Assets

1,22000Cr 1,41200Cr - - -

Interest Expense

- - - - -

CAPEX

-14TCr -7.12TCr - - -

Gross Profit

34TCr 45TCr - - -

D&A

4.34TCr 4.7TCr - - -

Operating Income

14TCr 15TCr - - -

Biological Products

          

Pharmaceuticals - Biotechnology (BIO)

- - 4.62TCr 5.4TCr 6.42TCr

Gross Profit

- - 1.68TCr 2.07TCr 2.57TCr

Operating Income

- - -2.07TCr -1.78TCr -1.33TCr

Pharmaceutical Product Distribution

          

Other

715Cr 971.7Cr 7.09TCr 2.5TCr 2.56TCr

Total Assets

410.4Cr 2.27TCr - - -

Interest Expense

- - - - -

CAPEX

-26Cr -31Cr - - -

Gross Profit

80Cr 63Cr 765.1Cr 543.2Cr 521.8Cr

D&A

20Cr 22Cr - - -

Operating Income

39Cr 14Cr -68Cr 103Cr 65Cr

Wholesale and Retail

13TCr 15TCr - - -

Total Assets

7.14TCr 8.59TCr - - -

Interest Expense

- - - - -

CAPEX

-60Cr -10Cr - - -

Gross Profit

1.02TCr 1.24TCr - - -

D&A

128.8Cr 137.3Cr - - -

Operating Income

46Cr -4.9Cr - - -

Eliminations

-1.58TCr -1.79TCr -1.32TCr -1.22TCr -1.06TCr

Total Assets

-15TCr -18TCr - - -

Interest Expense

- - - - -

CAPEX

2Cr - - - -

Gross Profit

-4.7Cr 1.9Cr -32Cr -52Cr 83Cr

D&A

- - - - -

Operating Income

-6.6Cr 137.5Cr -32Cr -52Cr 83Cr
Geographical breakdown of sales (HUF)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Europe

26TCr 33TCr 50TCr 51TCr 55TCr

Total Assets

16TCr 20TCr 1,32000Cr 1,55700Cr 1,65600Cr

CAPEX

-1.15TCr -1.84TCr -9.41TCr -6.31TCr -6.54TCr

North America

- - 22TCr 26TCr 28TCr

Total Assets

- - 309.2Cr 95Cr 98Cr

CAPEX

- - - -10L -

APAC

- - 4.31TCr 4.86TCr 5.47TCr

Total Assets

- - 1.46TCr 1.87TCr 1.57TCr

CAPEX

- - -34Cr -44Cr -89Cr

Latin America

1.76TCr 2.79TCr 3.17TCr 3.55TCr 3.83TCr

Total Assets

1.02TCr 2.02TCr 2.31TCr 2.62TCr 2.5TCr

CAPEX

-24Cr -28Cr -22Cr -22Cr -8.2Cr

Rest of The World

3.12TCr 3.65TCr 826.2Cr 670.6Cr 904.9Cr

Total Assets

1.46TCr 1.56TCr - - -

CAPEX

-46Cr -30Cr - - -

EU 12 (Excluding Poland and Romania)

- - - - -

China

1.56TCr 2.17TCr - - -

Total Assets

198.7Cr 505.7Cr - - -

Other CIS Republics

- - - - -

Ukraine

- - - - -

Russia

- - - - -

WEU

- - - - -

Poland

- - - - -

Romania

- - - - -

Hungary

4.44TCr 4.66TCr - - -

Total Assets

89TCr 1LCr - - -

CAPEX

-13TCr -5.21TCr - - -

CIS (Commonwealth of Independent States)

14TCr 18TCr - - -

Total Assets

7.05TCr 10TCr - - -

CAPEX

-396.2Cr -55Cr - - -

United States of America

12TCr 16TCr - - -

Total Assets

415.2Cr 286.2Cr - - -

CAPEX

- - - - -